It has been announced today the positive topline data from its pivotal Launch-HTN Phase 3 and pivotal Advance-HTN Phase 2 trials evaluating the efficacy and safety of lorundrostat for the treatment of...
Read moreThe trial, partially funded with an EU H2020 Grant (ClinGlio), has shown an improvement trend in progression-free survival (PFS) in MGMT-methylated patients receiving LAM561 in combination with chemor...
Read moreVarios centros del CSIC colaboran en el desarrollo de un compuesto eficaz frente a infecciones respiratorias virales como el coronavirus SARS-CoV-2 y el virus respiratorio sincitial
Read moreThe ICH, a non-profit international organization founded in 1990, developed the ICH guidelines as scientific consensus documents. The ICH guidelines full form stands for the International Council for ...
Read moreAugustine Therapeutics, focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase 6 (HDAC6) enz...
Read moreLas CROs (Organizaciones de Investigación por Contrato) desempeñan un papel esencial en la puesta en marcha y ejecución de ensayos clínicos. Desde la planificación inicial hasta la ejecución fin...
Read morePreviously unknown access points in cell membrane proteins have been discovered, enabling laboratory-developed drugs to modify cell function.
Read moreThe company develops innovative compounds that that RNA of cancer-driven genes. Its lead compound, currently advancing into the clinical phase, targets the treatment of malignant mesothelioma, a disea...
Read moreThe clinical-stage biotechnology company, Gain Therapeutics, has announced the administration of the first dose to a participant with Parkinson’s disease in its phase 1b clinical trial of GT-02287, ...
Read moreData from Advance-HTN support the potential of lorundrostat as a best-in-class treatment for high-risk patients with uncontrolled or resistant hypertension who would normally be treated in a specialis...
Read moreThe new compound is an inhibitor of soluble epoxide hydrolase (sEH), an enzyme involved in the regulation of several physiological processes, including inflammation and pain response. In the context o...
Read moreEste enfoque no invasivo consiste en gotas oftálmicas cargadas con el anticuerpo monoclonal adalimumab (ADA), dirigido contra la citoquina TNFα, involucrada en la inflamación de la retina.
Read more